Influenza Virus

1127 Words3 Pages

Influenza is one of the viruses that spread very fast and impacts a lot of people around the globe. At any given year, 20% of the population in the United States is expected to develop influenza pandemic (Palese and García-Sastre, 2002). In the US alone, there are more than 30,000 deaths a year just from influenza (Yang et al., 2013). Influenza virus is from the family Orthomyxoviridae with two main strains: Influenza A and B are the most common once to cause disease in human and they can be both circulating at the same time (Samji, 2009). This will mean there is a need for the development of a new vaccine against both strains every year to protect people from getting the flu. These two strains of influenza share the same genome that contains eight RNAs of negative sense polarity (Palese and García-Sastre, 2002). Also, influenza virus is an enveloped virus. The envelope is made up of lipid bilayer that contains three of the viral transmembrane proteins: hemagglutinin HA, neuraminidase NA, and matrix 2 M2 (Samji, 2009). Among these proteins, HA is the most abundant type of viral proteins in the viral envelope followed by NA then M2. One of the problems with controlling this virus is related to the fact that the proteins HA and NA are changing each year by single point mutations (aka antigenetic drift) (Yang et al., 2013). The life cycle of the virus is evolved around its survival and making more copies of itself. When influenza virus infects the host, the viral RNA proteins (vRNPs) enter the nucleus of the host and transcription and replication of the viral genome will start (Samji, 2009). Then the vRNPs is exported from the nucleus and start to assemble in the host’s cell plasma membrane (Samji, 2009). There are several approaches...

... middle of paper ...

...ount Sinai School of Medicine, New York, New York.
• Kanta Subbarao and Yumiko Matsuoka (2013). The Prospects and Challenges of Universal Vaccines for Influenza. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, USA.
• Natalie Pica and Peter Palese (2013). Toward a Universal Influenza Virus Vaccine: Prospects and Challenges. Department of Microbiology and 2Department of Medicine, Mount Sinai School of Medicine, New York.
• Peter Palese and Adolfo Garcia-Sastre (2002). Influenza Vaccines: Present and Future. Vol 110, Issue 1. Department of Microbiology, Mount Sinai School of Medicine. New York, USA. American Society for Clinical Investigation.
• Tasleem Samji (2009). Influenza A: Understating the Viral Life Cycle. Department of Microbiology, Yale University, Yale Journal of Biology and Medicine. Pg. 153-159.

More about Influenza Virus

Open Document